EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 89 filers reported holding EPIZYME INC in Q4 2015. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $30,000 | -9.1% | 20,664 | -27.2% | 0.00% | – |
| Q1 2022 | $33,000 | -2.9% | 28,400 | +106.0% | 0.00% | – |
| Q4 2021 | $34,000 | -42.4% | 13,784 | +20.2% | 0.00% | – |
| Q3 2021 | $59,000 | -97.4% | 11,469 | -93.9% | 0.00% | -100.0% |
| Q3 2020 | $2,257,000 | -25.0% | 189,218 | +0.9% | 0.02% | -40.0% |
| Q2 2020 | $3,011,000 | +207.2% | 187,467 | +97.4% | 0.02% | +177.8% |
| Q3 2019 | $980,000 | -38.8% | 94,966 | -10.3% | 0.01% | -30.8% |
| Q2 2019 | $1,601,000 | +1019.6% | 105,889 | +905.7% | 0.01% | +1200.0% |
| Q2 2018 | $143,000 | -24.7% | 10,529 | -1.4% | 0.00% | 0.0% |
| Q1 2018 | $190,000 | -5.9% | 10,680 | -33.7% | 0.00% | 0.0% |
| Q4 2017 | $202,000 | +267.3% | 16,100 | +198.3% | 0.00% | – |
| Q2 2016 | $55,000 | -5.2% | 5,398 | +13.8% | 0.00% | – |
| Q1 2016 | $58,000 | +70.6% | 4,745 | +121.1% | 0.00% | – |
| Q4 2015 | $34,000 | -2.9% | 2,146 | -22.2% | 0.00% | – |
| Q3 2015 | $35,000 | +66.7% | 2,758 | +216.6% | 0.00% | – |
| Q2 2015 | $21,000 | +250.0% | 871 | +180.1% | 0.00% | – |
| Q1 2015 | $6,000 | 0.0% | 311 | +6.1% | 0.00% | – |
| Q4 2014 | $6,000 | -40.0% | 293 | -17.7% | 0.00% | – |
| Q3 2014 | $10,000 | -16.7% | 356 | -5.3% | 0.00% | – |
| Q2 2014 | $12,000 | +33.3% | 376 | 0.0% | 0.00% | – |
| Q1 2014 | $9,000 | +125.0% | 376 | +76.5% | 0.00% | – |
| Q4 2013 | $4,000 | – | 213 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |